Russell Investments Group Ltd. Has $5.17 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Russell Investments Group Ltd. lifted its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 11.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 46,387 shares of the company’s stock after purchasing an additional 4,661 shares during the quarter. Russell Investments Group Ltd.’s holdings in Revvity were worth $5,172,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of RVTY. Orion Portfolio Solutions LLC increased its holdings in shares of Revvity by 51.6% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 4,746 shares of the company’s stock valued at $606,000 after acquiring an additional 1,616 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in Revvity by 5.1% during the third quarter. Coldstream Capital Management Inc. now owns 2,247 shares of the company’s stock valued at $286,000 after purchasing an additional 110 shares during the last quarter. Tidal Investments LLC raised its position in shares of Revvity by 2,388.8% in the third quarter. Tidal Investments LLC now owns 52,787 shares of the company’s stock valued at $6,744,000 after purchasing an additional 50,666 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Revvity by 3.1% in the third quarter. Principal Financial Group Inc. now owns 141,871 shares of the company’s stock worth $18,124,000 after buying an additional 4,263 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Revvity by 13.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company’s stock worth $43,961,000 after buying an additional 41,497 shares during the period. Institutional investors own 86.65% of the company’s stock.

Insider Buying and Selling at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares of the company’s stock, valued at $4,232,782. This trade represents a 31.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.68% of the company’s stock.

Revvity Trading Up 2.8 %

Shares of RVTY stock opened at $97.51 on Tuesday. The firm has a fifty day moving average of $108.62 and a 200-day moving average of $114.90. The stock has a market cap of $11.72 billion, a price-to-earnings ratio of 44.12, a P/E/G ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a 52-week low of $89.61 and a 52-week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the firm earned $1.25 earnings per share. On average, equities research analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio is 12.67%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Raymond James reiterated an “outperform” rating and issued a $145.00 target price (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Barclays cut their price objective on Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. KeyCorp raised their target price on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, Sanford C. Bernstein lowered Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $133.75.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.